The latest OTC stock news has not been good for a penny stock investor’s portfolio. We are all looking at a sea...
There’s not much we can say, except that it sucks to be a penny stock investor right now. We follow hundreds of...
Lately, there has not been a lot to get excited about in the OTC Stock Markets. Except for the recent 2085% run...
There’s not a lot to get excited about in the OTC Markets right now, except for Regen BioPharma (OTCMKTS: RGBP). Shares of...
The ADHD market is over $10B yearly in the US. Last week, Kempharm (NASDAQ: KMPH) announced a very positive restructuring of their...
In this video, Alex Carlson, the editor-in-chief of Insider Financial, discusses last week’s price action and his outlook for April 12 to...
The entire OTC Market is talking about just one stock this week and that’s Regen BioPharma (OTCMKTS: RGBP). The stock rocketed 957% in...
CytoDyn Inc. (OTCMKTS: CYDY) announced yesterday that it shipped 28 doses of leronlimab under Compassionate Special Permit (CSP) to one hospital in...
We are starting to see some stability in today’s OTC stocks list. The last few weeks have been hard on many OTC...
We are starting to see some stability in the OTC Markets. The last few weeks have been hard on many OTC traders...
